North Growth Management Ltd. Bristol Myers Squibb CO Transaction History

North Growth Management Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 18, 2023	SELL	$57.89 - $64.73 $1.45 Million - $1.62 Million	-25,000 Reduced 11.36%	195,000 $11.3 Million
Q1 2023 May 03, 2023	SELL	$65.71 - $74.53 $197,129 - $223,590	-3,000 Reduced 1.35%	220,000 $15.2 Million
Q4 2022 Feb 09, 2023	SELL	$68.48 - $81.09 $2.19 Million - $2.59 Million	-32,000 Reduced 12.55%	223,000 $16.1 Million
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $122,960 - $147,440	2,000 Added 0.79%	255,000 $18.6 Million
Q2 2021 Jul 15, 2021	BUY	$61.91 - $67.42 $1.24 Million - $1.35 Million	20,000 Added 8.58%	253,000 $16.9 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $1.36 Million - $1.54 Million	23,000 Added 10.95%	233,000 $14.7 Million
Q4 2020 Feb 10, 2021	SELL	$57.74 - $65.43 $923,840 - $1.05 Million	-16,000 Reduced 7.08%	210,000 $13 Million
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $1.15 Million - $1.27 Million	20,000 Added 9.71%	226,000 $13.6 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $1.1 Million - $1.28 Million	20,000 Added 10.75%	206,000 $12.1 Million
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $1.76 Million - $2.56 Million	38,000 Added 25.68%	186,000 $10.4 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $1.97 Million - $2.33 Million	46,000 Added 45.1%	148,000 $7.53 Million
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $4.55 Million - $5.03 Million	102,000 New	102,000 $4.63 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of North Growth Management Ltd., based on Form 13F filings with the SEC.

Stay updated on North Growth Management Ltd. with notifications on news.